Standard BioTools
LAB
LAB
119 hedge funds and large institutions have $387M invested in Standard BioTools in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 39 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 76.82% → 76.98% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
18% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 39
Holders
119
Holding in Top 10
2
Calls
$4.08M
Puts
$1.35M
Top Buyers
| 1 | +$2.64M | |
| 2 | +$2.1M | |
| 3 | +$2.03M | |
| 4 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$1.88M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.54M |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$1.07M | |
| 3 | -$887K | |
| 4 |
Jennison Associates
New York
|
-$830K |
| 5 |
CAM
Connacht Asset Management
New York
|
-$796K |